Marianne Böni-Schnetzler and Marc Y. Donath How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes British Journal of Clinical Pharmacology 76
Article first published online: 23 JUL 2013 | DOI: 10.1111/j.1365-2125.2012.04297.x
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.